184 related articles for article (PubMed ID: 26552699)
1. Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
Kaczkowski B; Tanaka Y; Kawaji H; Sandelin A; Andersson R; Itoh M; Lassmann T; Hayashizaki Y; Carninci P; Forrest AR;
Cancer Res; 2016 Jan; 76(2):216-26. PubMed ID: 26552699
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Tsai YS; Dominguez D; Gomez SM; Wang Z
Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
[TBL] [Abstract][Full Text] [Related]
3. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.
Yu K; Chen B; Aran D; Charalel J; Yau C; Wolf DM; van 't Veer LJ; Butte AJ; Goldstein T; Sirota M
Nat Commun; 2019 Aug; 10(1):3574. PubMed ID: 31395879
[TBL] [Abstract][Full Text] [Related]
5. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
[TBL] [Abstract][Full Text] [Related]
7. Assessing the clinical utility of genomic expression data across human cancers.
Xu X; Huang L; Chan CH; Yu T; Miao R; Liu C
Oncotarget; 2016 Jul; 7(29):45926-45936. PubMed ID: 27322207
[TBL] [Abstract][Full Text] [Related]
8. Pan-organ transcriptome variation across 21 cancer types.
Hu W; Yang Y; Li X; Zheng S
Oncotarget; 2017 Jan; 8(4):6809-6818. PubMed ID: 28036280
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome Profiling in Human Diseases: New Advances and Perspectives.
Casamassimi A; Federico A; Rienzo M; Esposito S; Ciccodicola A
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758927
[TBL] [Abstract][Full Text] [Related]
10. The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data.
Machnik M; Cylwa R; Kiełczewski K; Biecek P; Liloglou T; Mackiewicz A; Oleksiewicz U
Mol Oncol; 2019 Apr; 13(4):701-724. PubMed ID: 30444046
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
Huang X; Stern DF; Zhao H
Sci Rep; 2016 Feb; 6():20567. PubMed ID: 26837275
[TBL] [Abstract][Full Text] [Related]
12. Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Mandel J; Avula R; Prochownik EV
BMC Cancer; 2020 Apr; 20(1):297. PubMed ID: 32264880
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.
Federico A; Rienzo M; Abbondanza C; Costa V; Ciccodicola A; Casamassimi A
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468258
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
Wang J; Liu Q; Shyr Y
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S5. PubMed ID: 26100984
[TBL] [Abstract][Full Text] [Related]
15. PR/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas.
Sorrentino A; Federico A; Rienzo M; Gazzerro P; Bifulco M; Ciccodicola A; Casamassimi A; Abbondanza C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347759
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
Mandel J; Wang H; Normolle DP; Chen W; Yan Q; Lucas PC; Benos PV; Prochownik EV
BMC Cancer; 2019 Jul; 19(1):686. PubMed ID: 31299925
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the Utility of Cancer Transcriptomic Data.
Xiang Y; Ye Y; Zhang Z; Han L
Trends Cancer; 2018 Dec; 4(12):823-837. PubMed ID: 30470304
[TBL] [Abstract][Full Text] [Related]
18. A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters.
Demircioğlu D; Cukuroglu E; Kindermans M; Nandi T; Calabrese C; Fonseca NA; Kahles A; Lehmann KV; Stegle O; Brazma A; Brooks AN; Rätsch G; Tan P; Göke J
Cell; 2019 Sep; 178(6):1465-1477.e17. PubMed ID: 31491388
[TBL] [Abstract][Full Text] [Related]
19. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
[TBL] [Abstract][Full Text] [Related]
20. Gene Expression Integration into Pathway Modules Reveals a Pan-Cancer Metabolic Landscape.
Cubuk C; Hidalgo MR; Amadoz A; Pujana MA; Mateo F; Herranz C; Carbonell-Caballero J; Dopazo J
Cancer Res; 2018 Nov; 78(21):6059-6072. PubMed ID: 30135189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
